Market revenue in 2023 | USD 37.8 million |
Market revenue in 2030 | USD 208.9 million |
Growth rate | 27.7% (CAGR from 2023 to 2030) |
Largest segment | Software |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Hardware, Services |
Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 47.88% in 2023. Horizon Databook has segmented the Europe artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare systems in Europe are overburdened due to increasing costs, rising incidence of cancer cases, increasing demand for healthcare facilities, and stagnating or shrinking healthcare workforce. The industry also faces issues due to structural inefficiencies in certain European countries. The move to value-based healthcare is expected to strengthen patient outcomes at a more sustainable cost.
Incorporating AI into innovative medical technologies can help address the pressing healthcare issues. In addition, increasing investments in AI in healthcare are driving the market growth. For instance, in October 2019, the UK government announced an investment of USD 300 billion in AI, which is expected to be utilized by the public healthcare system to improve the quality of care.
Many AI applications are already in operation or awaiting deployment, which can contribute to earlier cancer detection, more accurate diagnosis, identification of new observations or patterns in human physiology, and development of personalized diagnostics & therapeutics.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account